TP53 and neoplasm: Furthermore, other groups have specifically reported that IL-1 enhances the sensitivity of tumour cells to cisplatin and that synergistic interactions between IL-1 and cisplatin may actually enhance p53-dependent apoptosis (Benchekroun et al. 1993; Poppenborg et al. 1999; Song et al. 1998).